Pfizer 1Q sales and profit down, but it maintains 2020 views
Drugmaker Pfizer said the COVID-19 pandemic will reduce its second-quarter sales, as quarantines around the world are reducing visits to doctors — by patients with chronic conditions, parents bringing in kids needing shots and the company's sales representatives.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
